Trial Profile
Phase II study of gemcitabine and pemetrexed in primary unknown adenocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Oct 2006
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 11 Oct 2006 New trial record.